Vertex Pharmaceuticals, Inc’s recent filing unveils that its CEO & President Kewalramani Reshma acquired Company’s shares for reported $3.9 million on Aug 06 ’25. In the deal valued at $389.58 per share,10,000 shares were bought. As a result of this transaction, Kewalramani Reshma now holds 115,968 shares worth roughly $43.43 million.
Then, SACHS BRUCE I bought 5,000 shares, generating $1,948,416 in total proceeds. Upon buying the shares at $389.68, the Director now owns 45,000 shares.
Before that, LR 2019 Benefit Trust bought 170 shares. Vertex Pharmaceuticals, Inc shares valued at $76,021 were divested by the Director at a price of $447.18 per share.
Wells Fargo upgraded its Vertex Pharmaceuticals, Inc [VRTX] rating to an Overweight from a an Equal weight in a research note published recently. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who decreased its forecast for the stock in early May from “an Outperform” to “a Peer perform”. Leerink Partners also remained covering VRTX and has decreased its forecast on May 06, 2025 with a “Market perform” recommendation from previously “an Outperform” rating.
Price Performance Review of VRTX
On Monday, Vertex Pharmaceuticals, Inc [NASDAQ:VRTX] saw its stock jump 2.16% to $374.46. Over the last five days, the stock has lost -20.71%. Vertex Pharmaceuticals, Inc shares have fallen nearly -19.62% since the year began. Nevertheless, the stocks have fallen -7.01% over the past one year. While a 52-week high of $519.88 was reached on 03/14/25, a 52-week low of $364.66 was recorded on 08/11/25.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 364.57, which if violated will result in even more drops to 354.69. On the upside, there is a resistance level at 382.27. A further resistance level may holdings at 390.09.
How much short interest is there in Vertex Pharmaceuticals, Inc?
A steep rise in short interest was recorded in Vertex Pharmaceuticals, Inc stocks on 2025-07-15, growing by 0.15 million shares to a total of 4.19 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 4.03 million shares. There was a rise of 3.66%, which implies that there is a positive sentiment for the stock.
